| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2003 | CN1104905C Novel powder compositions |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104899C Injectable quinolone formulations |
| 04/09/2003 | CN1104898C Ocular tension depressant |
| 04/09/2003 | CN1104897C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/09/2003 | CN1104895C Composition comprising tramadol material and acetaminophen and its use |
| 04/09/2003 | CN1104894C Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/09/2003 | CN1104893C Percutaneous tulobuterol preparation and process for producing same |
| 04/09/2003 | CN1104892C Method for curing tinnitus by nerve protecting agent |
| 04/09/2003 | CN1104891C Controlled release preparation |
| 04/09/2003 | CN1104855C Composition and its use as food supplement or for lowering lipids in serum |
| 04/09/2003 | CN1104845C Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed |
| 04/08/2003 | WO2004028529A1 Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | USRE38071 Method for treating infectious respiratory diseases |
| 04/08/2003 | US6546281 Integrated apparatus for controlled heat aided dermal drug delivery |
| 04/08/2003 | US6545182 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/08/2003 | US6545174 Contaning diarylbutadienes |
| 04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
| 04/08/2003 | US6545155 Fused heteroaromatic glucokinase activators |
| 04/08/2003 | US6545153 Anticholesterol agents; antilipemic agents |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545138 Nucleic acid complex |
| 04/08/2003 | US6545136 Process for producing desulfated polysaccharide, and desulfated heparin |
| 04/08/2003 | US6545131 Tissue specific prodrug |
| 04/08/2003 | US6545127 Catalytically active recombinant memapsin and methods of use thereof |
| 04/08/2003 | US6545097 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
| 04/08/2003 | US6545058 Contains terpenoid as active ingredient |
| 04/08/2003 | US6545057 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/08/2003 | US6545056 Aryl nitrone therapeutics and methods for treating inflammatory bowel disease |
| 04/08/2003 | US6545055 Amidino-phenyl or -naphthyl aromatic amide derivatives |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. |
| 04/08/2003 | US6545052 Contacting skin with skin treatment composition having concentration of 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation |
| 04/08/2003 | US6545051 Antibacterial hydroxamic acid derivatives |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545046 Method for enhanced delivery of oxybutynin and compositions thereof |
| 04/08/2003 | US6545045 Administering to an effected eye rioprostil, SC 46275, enisoprost, misoprostol, nocloprost, enprostil, 11-deoxy-16-16-dimethyl- PGE2, and 16,16-dimethyl-PGE2, or esters or cationic salts thereof |
| 04/08/2003 | US6545044 Compositions of matter containing L-glutamine and pyridoxal-alpha-ketoglutarate |
| 04/08/2003 | US6545041 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals |
| 04/08/2003 | US6545040 Method of lowering the blood pressure |
| 04/08/2003 | US6545039 Facilitated administration of α-lipoic acid or derivatives thereof |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group |
| 04/08/2003 | US6545034 Effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent. |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545028 Antiepileptic agents, hypotensive agents; monitoring membrane potentials |
| 04/08/2003 | US6545027 Methods of modulating NF-kB transcription factor |
| 04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545021 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 04/08/2003 | US6545020 Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties |
| 04/08/2003 | US6545019 Administration to a human in need thereof a compound capable of inhibiting 5-LOX (lipoxygenase) for modulating microglia activation |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/08/2003 | US6545016 Inducing cytokine biosynthesis; treating a viral and neoplastic diseases |
| 04/08/2003 | US6545015 Useful in therapy of bacterial infections, fungal infections |
| 04/08/2003 | US6545014 Glaucoma; adjusting concentration of nitric oxide; hypotensive, antispasmodic, antiischemic, cardiotonic agents; bronchodilators; urogentital disorders; agonists, antagonists for endothelin receptors |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545010 Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
| 04/08/2003 | US6545008 Pyrimidine derivatives and processes for the preparation thereof |
| 04/08/2003 | US6545007 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 04/08/2003 | US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/08/2003 | US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity. |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6545001 Antiviral nucleoside analogues |
| 04/08/2003 | US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 04/08/2003 | US6544997 E.g., hypermotility, irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity and/or hyperactivity |
| 04/08/2003 | US6544996 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands |
| 04/08/2003 | US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein |
| 04/08/2003 | US6544994 Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544992 Carbonylamino pyrrolidine and piperidine derivatives |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits |
| 04/08/2003 | US6544983 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544980 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
| 04/08/2003 | US6544979 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 04/08/2003 | US6544978 Treating Alzheimer's disease both prophylactically and therapeutically |
| 04/08/2003 | US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide |
| 04/08/2003 | US6544975 Mimetics that inhibit lipid peroxidation; for use in the treatment of diseases or disorders mediated by oxidative stress, such as asthma, inflammatory bowel disease, arthritis and vasculitis. |
| 04/08/2003 | US6544972 Contacting such cells with a hydrophilic bile acid, such as ursodeoxycholic acid or salts thereof; |
| 04/08/2003 | US6544971 Alarm device especially for detecting fires, unauthorized entry or sleep apnea, or the presence of CO, CH4, propane or radon |
| 04/08/2003 | US6544970 Administering in a first phase of a progestational agent (levonorgestrel or ethinylestradiol) and in a second phase an antiprogestin that is an indolinone derivative, especially a 3-spiroalkylene derivative |
| 04/08/2003 | US6544969 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 04/08/2003 | US6544968 Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 04/08/2003 | US6544967 Orally administering to mammal a pharmaceutically effective amount of a bisphosphonate as a unit dosage according to a continuous schedule having a desired dosing interval; osteoporosis |
| 04/08/2003 | US6544965 Compounds with an antioxidant activity, compositions useful as food integrators containing them and process for their preparation |
| 04/08/2003 | US6544964 Cyclodextrin derivatives in which at least one of the hydroxy groups has been methylated whilst the other hydroxy groups may be modified by methyl groups or other groups, for complexing lead ions. |
| 04/08/2003 | US6544963 Alkali metal or alkali earth metal salt of carboxylmethyl cellulose, and a carrier; promoting cellular adhesion, wound healing, controlling bleeding |
| 04/08/2003 | US6544962 Methods for treating cellular proliferative disorders |
| 04/08/2003 | US6544961 Especially for treatment of infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors. |